Open Access
Research Article

Table 1

Comparison between clinical and geographic data of the responder and non-responder groups involved in the study.

Patient data Responders (n = 23) Non-responders (n = 21)
Gender    
  Female 11 (47.8%) 7 (33.3%)
  Male 12 (52.2%) 14 (66.7%)
Age (mean)    
  Mean ± SD 36.04 ± 11.13 32.29 ± 13.37
Number of skin lesions    
  Median (min–max) 1 (1–7) 1 (1–15)
Lesion location    
  Lower extremity 10 (43.5%) 13 (61.9%)
  Upper limbs 7 (30.4%) 6 (28.6%)
  Head and cervical-facial 1 (4.3%) 5 (23.8%)
  Torso 7 (30.4%) 2 (9.5%)
Lesion-evolution time (days)    
  Median (min–max) 60 (30–150) 60 (20–270)
Number of treatmentsa    
   Median (min–max) 1 (1–1) 2 (2–4)
MST    
  Reactor 22 (100%) 18 (94.7%)
  Non-reactor 1 (5.3%)
MST values (mm)b    
  Median (min–max) 20 (7–60) 12 (4–27)
ELISA    
  Reactor 16 (76.2%) 17 (89.5%)
   Non-reactor 5 (23.8%) 2 (10.5%)
IIFc    
   Reactor 9 (42.9%) 17 (94.4%)
   Non-reactor 12 (57.1%) 1 (5.6%)
Region of Infection    
   Rio de Janeiro 18 (78.3%) 17 (81%)
   Other states 5 (21.7%) 4 (19%)

MST = Montenegro Skin Test; IIF = Indirect Immunofluorescence; RJ = Rio de Janeiro; OS = other states.

Mean ± SD = Mean and standard deviation.

p < 0.05 values are considered significant.

a

p < 0.001 (Mann-Whitney U Test).

b

p = 0.048 (Mann-Whitney U Test).

c

p = 0.001 (Fisher's Exact Test).

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.